Impact of Exercise Intervention on the Phenome
1 other identifier
interventional
270
1 country
2
Brief Summary
It is an open-label, parallel-group, randomized controlled clinical trial, which is designed to enroll people with different glucose metabolism status who are also overweight or obese, including people with normal glucose metabolism, pre-diabetes patients and newly diagnosed type 2 diabetes patients. The patients are randomized to an enhanced physical activity intervention (high-intensity interval training exercise prescription combined with resistance training) or standard education group (diabetes health education only, including lifestyle education and guidance) for 12 weeks. This trial intends to compare the influence of enhanced physical activity treatment with that of a standard education on liver steatosis, serum glucose and lipids level, insulin sensitivity, cardiovascular metabolic parameters, metabolic molecules, and gut microbiota profile et al.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2021
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2021
CompletedFirst Posted
Study publicly available on registry
June 9, 2021
CompletedStudy Start
First participant enrolled
June 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2023
CompletedJune 9, 2021
June 1, 2021
12 months
April 22, 2021
June 2, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in liver steatosis quantified by MRI-PDFF (percentage)
12 weeks
Secondary Outcomes (30)
Change in liver steatosis quantified by MRI-PDFF (percentage)
1 year
Change in the level of fasting blood glucose (mmol/l)
12 weeks and 1 year
Change in the level of plasma glucose of 2 hours post glucose-load (mmol/l)
12 weeks and 1 year
Change in the level of HbA1c (percentage)
12 weeks and 1 year
Change in body mass index (BMI)
12 weeks and 1 year
- +25 more secondary outcomes
Study Arms (2)
Enhanced physical activity group
EXPERIMENTALthe participants will take high-intensity exercise in accordance with High Intensity Interval Training (HIIT) prescriptions, with maximum heart rate and relative maximal oxygen uptake monitored. They will take both aerobic and resistance training exercise consecutively, and total training time will be expected to reach at least 150 minutes per week.
Standard education group
EXPERIMENTALthe participants will receive no extra intervention but diabetes health education, which will be carried out in large classrooms, in groups, and over the telephone. The education is mainly consisted of instructions on diabetes prevention according to \< Guidelines for prevention and treatment of type 2 diabetes in China (2017 edition)telephone. The education is mainly consisted of instructions on diabetes prevention according to \< Guidelines for prevention and treatment of type 2 diabetes in China (2017 edition)\>.
Interventions
the participants will take high-intensity exercise in accordance with High Intensity Interval Training (HIIT) prescriptions, with maximum heart rate and relative maximal oxygen uptake monitored. They will take both aerobic and resistance training exercise consecutively, and total training time will be expected to reach at least 150 minutes per week.
the participants will receive no extra intervention but diabetes health education, which will be carried out in large classrooms, in groups, and over the telephone. The education is mainly consisted of instructions on diabetes prevention according to \< Guidelines for prevention and treatment of type 2 diabetes in China (2017 edition)
Eligibility Criteria
You may qualify if:
- Men and women aged 18-65 years;
- Normal glucose metabolism or pre-diabetes or newly diagnosed type 2 diabetes
- Normal glucose metabolism:
- FBG\<5.6mmol/L and
- h-PG\<7.8mmol/L and
- HbA1c\<5.7%;
- Pre-diabetes:
- mmol/L ≤ FBG ≤ 6.9mmol/L and/or
- mmol/L ≤ 2h-PG ≤ 11.0mmol/L and/or
- % ≤ HbA1c ≤ 6.4%;
- Newly diagnosed diabetes:
- o Duration of type 2 diabetes is less than 5 years;
- No insulin treatment;
- Kg/m2 ≤ Body mass index (BMI) \<40 Kg/m2;
You may not qualify if:
- Eligibility Minimum Age: 18 Years Maximum Age: 65 Years Sex: All Gender Based: No Accepts Healthy Volunteers: No
- Men and women aged 18-65 years;
- Normal glucose metabolism or pre-diabetes or newly diagnosed type 2 diabetes
- Normal glucose metabolism:
- FBG\<5.6mmol/L and
- h-PG\<7.8mmol/L and
- HbA1c\<5.7%;
- Pre-diabetes:
- mmol/L ≤ FBG ≤ 6.9mmol/L and/or
- mmol/L ≤ 2h-PG ≤ 11.0mmol/L and/or
- % ≤ HbA1c ≤ 6.4%;
- Newly diagnosed diabetes:
- o Duration of type 2 diabetes is less than 5 years;
- No insulin treatment;
- Kg/m2 ≤ Body mass index (BMI) \<40 Kg/m2;
- +24 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Shanghai Institute of Endocrine and Metabolic Diseases
Shanghai, Shanghai Municipality, 200025, China
The Third People's Hospital of Datong City
Datong, Shanxi, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 22, 2021
First Posted
June 9, 2021
Study Start
June 15, 2021
Primary Completion
May 30, 2022
Study Completion
May 30, 2023
Last Updated
June 9, 2021
Record last verified: 2021-06